Myasthenia Gravis, MuSK
4 clinical trials · Condition
◉ Watch Myasthenia Gravis, MuSK
| Record | Firm | Date |
|---|---|---|
| AXIS MG Patient Registry (NCT07761026) | Autoimmune Neurology Alliance | 2026-03-19 |
| Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis (NCT06414954) | NMD Pharma A/S | 2024-05-16 |
| Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis) (NCT03579966) | Catalyst Pharmaceuticals, Inc. | 2018-06-11 |
| Myasthenia Gravis Foundation of America Global MG Patient Registry (NCT06617741) | Myasthenia Gravis Foundation of America | 2013-10-12 |
Track Myasthenia Gravis, MuSK automatically
Every clearance here is in the API, with alerts when new ones post.